Staphylococcal endocarditis

Current Opinion in Infectious Diseases

Volumn 9, Issue 2, 1996, Pages 105-108

  Watanakunakorn, Chatrchai ^a,b  

^a ST ELIZABETH HEALTH CENTER   (United States)

^b NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

BACTERIAL ENDOCARDITIS; CLINICAL FEATURE; INCIDENCE; SHORT SURVEY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

EID: 0030010145     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-199604000-00013     Document Type: Short Survey

References (32)

1. Watanakunakorn C, Tan JS, Phair JP: Some salient features of Staphylococcus aureus endocarditis. Am J Med 1973, 54:473-481.
2. Watanakunakorn C, Tan JS: Diagnostic difficulties of staphylococcal endocarditis in geriatric patients. Geriatrics 1973, 28:168-173.
3. Espersen F, Frimodt-Moller N: Staphylococcus aureus endocarditis: a review of 119 cases. Arch Intern Med 1986, 146:118-121.
4. Watanakunakorn C: Staphylococcus aureus endocarditis at a community teaching hospital, 1980 to 1991. An analysis of 106 cases. Arch Intern Med 1994, 154:2330-2335. This is the largest series of S. aureus endocarditis from a community hospital in the USA, treated in the 1980s. Old age, congestive heart failure and central nervous system involvement were each associated with a higher incidence of mortality.
5. Watanakunakorn C, Burkert T: Infective endocarditis at a large community teaching hospital, 1980-1990: a review of 210 episodes. Medicine 1993, 12:90-102.
6. Dwyer DE, Chen SCA, Wright EJ, Crimmins D, Collignon P, Sorrell TC: Hospital practices influence the pattern of infective endocarditis. Med J Aust 1994, 160:709-718.
7. Choudhury R, Grover A, Varma J, Khattri HN, Anan IS, Bidwai PS, Wahi PL, Sapru RP: Active infective endocarditis observed in an Indian hospital 1981-1991. Am J Cardiol 1992, 70:1453-1458.
8. Sanabria TJ, Alpert JS, Goldberg R, Pape LA, Cheeseman SH: Increasing frequency of staphylococcal infective endocarditis. Experience at a university hospital, 1981 through 1988. Arch Intern Med 1990, 150:1305-1309.
9. Fernandez-Guerrero ML, Verdejo C, Azofra J, de Gorgolas M: Hospital-acquired infectious endocarditis not associated with cardiac surgery: an emerging problem. Clin Infect Dis 1995, 20:16-23. The most recent article on hospital-acquired infective endocarditis. At a tertiary-care hospital in Spain 9.3% of infective endocarditis cases were hospital-acquired; 65% of these cases were associated with intravenous catheterization. S. aureus was the predominant organism.
10. Vandenesch F, Etienne J, Reverdy ME, Eykyn SJ: Endocarditis due to Staphylococcus lugdunensis: report of 11 cases and review. Clin Infect Dis 1993, 17:871-876. This is an excellent review of S. lugdunensis endocarditis. Its clinical course is similar to that of S. aureus endocarditis.
11. Breen JD, Karchmer AW: Usefulness of pulsed-field gel electrophoresis in confirming endocarditis due to Staphylococcus lugdunensis. Clin Infect Dis 1994, 19:985-986.
12. Kralovic SM, Melin-Aldana H, Smith KK, Linnemann CC Jr: Staphylococcus lugdunensis endocarditis after tooth extraction. Clin Infect Dis 1995, 20:715-716.
13. Watanakunakorn C, Baird IM: Staphylococcus aureus bacteremia and endocarditis associated with a removable infected intravenous device. Am J Med 1977, 63:253-256.
14. Jernigan JA, Farr BM: Short-course therapy of catheter-related Staphylococcus aureus bacteremia: a meta-analysis. Ann Intern Med 1993, 119:304-311.
15. Melanowski GJ, Samore MH, Pefanis A, Karchmer AW: Staphylococcus aureus catheter-associated bacteremia. Minimal effective therapy and unusual infectious complications associated with arterial sheath catheters. Arch Intern Med 1995, 155:1161-1166. A retrospective review of 55 cases of S. aureus bacteremia associated with intravascular catheters. The authors concluded that a 10- to 15-day course of intravenous antibiotic was adequate therapy.
16. Herchline TE, Ayers LW: Occurrence of Staphylococcus lugdunensis in consecutive clinical cultures and relationship of isolation to infection. J Clin Microbiol 1991, 29:419-421.
17. Rupp ME, Archer GL: Coagulase-negative staphylococci: pathogens associated with medical progress. Clin Infect Dis 1994, 19:231-245.
18. Blumberg EA, Karalis DA, Chandrasekaran K, Wahl JM, Vilaro J, Covalesky VA, Mintz GS: Endocarditis associated paravalvular abscesses. Do clinical parameters predict the presence of abscess? Chest 1995, 107:898-903.
19. Pedersen WR, Walker M, Olson JD, Gobel F, Lange HW, Daniel JA, Rogers J, Longe T, Kane M, Mooney MR et al.: Value of transesophageal echocardiography as an adjunct to transthoracic echocardiography in evaluation of native and prosthetic valve endocarditis. Chest 1991, 100:351-356.
20. Daniel WG, Mugge A, Martin RP, Linert O, Hausmann D, Donnast-Daniel B, Laas J, Lichtlen PR: Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. N Engl J Med 1991, 324:795-800. This large study on 118 consecutive patients with infective endocarditis showed that transesophageal echocardiography contributes to a significant improvement in the diagnosis of endocarditis-associated abscesses.
21. Watanakunakorn C, Glotzbecker C: Enhancement of the effects of anti-staphylococcal antibiotics by aminoglycosides. Antimicrob Agents Chemother 1974, 6:802-806.
22. Watanakunakorn C, Glotzbecker C: Enhancement of antistaphylococcal activity of nafcillin and oxacillin by sisomicin and netilmicin. Antimicrob Agents Chemother 1977, 12:346-348.
23. Chambers HF, Miller RT, Newman MD: Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two week combination therapy. Ann Intern Med 1988, 109:619-624.
24. Torres-Tortosa M, de Cueto M, Vergara A, Sanchez-Porto A, Perez- Guzman E, Gonzalez-Serrano M, Canneto J, Grupo de Estudio de Enfermedades Infecciosas de la Provincia de Cádiz: Prospective evaluation of a two-week course of intravenous antibiotics in intravenous drug addicts with infective endocarditis. Eur J Clin Microbiol Infect Dis 1994, 13:559-564.
25. Fortun J, Perez-Molina JA, Anon MT, Martinez-Beltran J, Loza E, Guerrero A: Right-sided endocarditis caused by Staphylococcus aureus in drug abusers. Antimicrob Agents Chemother 1995, 39:525-528. Teicoplanin at a dosage of 7 mg/kg per day was associated with failure, even if a dosage of 12 mg/kg per day was given during the first week.
26. Mamardi J-L, Shlaes DM, Goering RV, Shlaes JH, Acar JF, Goldstein FW: Decreased teicoplanin susceptibility of methicillin-resistant strains of Staphylococcus aureus. J Infect Dis 1995, 171:1646-1650. Clinical isolates of methicillin-resistant S. aureus have been shown to have decreased teicoplanin susceptibility in France where teicoplanin has been used extensively.
27. Watanabe G, Haverich A, Speier R, Dresler C, Borst HG: Surgical treatment of active infective endocarditis with paravalvular involvement. J Thorac Cardiovasc Surg 1994, 107:171-177.
28. Mullany CJ, Chua YL, Schaff HV, Steckelberg JM, Ilstrup DM, Orszulak TA, Danielson GK, Puga FJ: Early and late survival after surgical treatment of culture-positive active endocarditis. Mayo Clim Proc 1995, 70:715-725. A 30-year experience with 151 patients. The operative mortality was 26%. A trend towards a higher mortality was noted with staphylococcal infection. The 5- and 10-year survival was 71% and 60%, respectively.
29. Mathew J, Addai T, Anaud A, Morrobel A, Maheshwari P, Freels S: Clinical features, site of involvement, bacteriologic findings, and outcome of infective endocarditis in intravenous drug users. Arch Intern Med 1995, 155:1641-1648.
30. Mathew J, Abreo G, Namburi K, Narra L, Franklin C: Results of surgical treatment for infective endocarditis in intravenous drug users. Chest 1995, 108:73-77.
31. de Gorgolas M, Aviles P, Verdejo C, Fernandez Guerrero ML: Treatment of experimental endocarditis due to methicillin- susceptible or methicillin-resistant Staphylococcus aureus with trimethoprim-sulfamethoxazole and antibiotics that inhibit cell wall synthesis. Antimicrob Agents Chemother 1995, 39:953-957.
32. Brandt CM, Rouse MS, Tallan BM, Laue NW, Wilson WR, Steckelberg JM: Effective treatment of cephalosporin-rifampin combinations against cryptic methicillin-resistant β-lactamase producing coagulase-negative staphylococcal experimental endocarditis. Antimicrob Agents Chemother 1995, 39:1815-1819.